CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach may spare heart and lungs in esophageal cancer patients
Disease control Recruiting nowThis study compares two radiation methods for people with stage I to IVA esophageal cancer: proton beam therapy and standard photon radiation (IMRT). The goal is to see which one helps patients live longer and causes fewer serious heart and lung side effects. About 300 adults wil…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Cancer care at home: a new study tests if shots are better than clinic visits
Symptom relief Recruiting nowThis study looks at whether giving the cancer drug nivolumab as a shot at home is as good as getting it in a clinic. It aims to reduce the time, cost, and stress of traveling for treatment. About 50 adults with various advanced cancers will try both settings and report which they…
Matched conditions: CLINICAL STAGE II ESOPHAGEAL SQUAMOUS CELL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 16, 2026 23:21 UTC